12 results
Kawasaki Disease - Workup and Diagnostic Algorithm #Diagnosis #Management #Peds #Pediatrics #Kawasaki #Disease #Algorithm #CRASH #BURN
Kawasaki Disease ... #Diagnosis #Management ... #Peds #Pediatrics ... #Kawasaki #Disease ... #Algorithm #CRASH
Pediatric UTI Algorithm (2-24 months of age)

Risk stratify with UTI Calc: 
 - Age months
Pediatric UTI Algorithm ... months of age) Risk ... Emergency Medicine Cases ... #Diagnosis #Management ... UrinaryTractInfection #Peds
Vibrio Vulnificus skin infection
Cirrhosis w/recent consumption of raw oysters w/rapidly evolving rash. 
Vibrio vulnificus part of
necrotic ulcers Risk ... chronic liver disease ... immunosuppressive meds ... University Infectious Diseases ... dermatology #legs #clinical
Monkeypox

What?
Monkeypox virus belongs to the family Poxviridae, subfamily Chordopoxvirinae, and genus orthopoxvirus
Viral zoonotic disease that is
Viral zoonotic disease ... that is caused ... + risk factors ... three weeks Clinical ... #Diagnosis #Management
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
40, F:M 9:1 • Clinical ... Manifestations: Malar rash ... Positive in 60-80% of cases ... - pANCA anti-MPO ... Evolution: Chronic disease
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... - pANCA anti-MPO ... - pANCA anti-MPO ... Evolution: Chronic disease
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
fatigue despite clinical ... remission • Risk ... fatigue despite disease ... /other causes • ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Ischemic heart disease ... event, follow ACC algorithm ... Change in clinical ... Cataract Plan for Meds ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... Valvular heart disease ... Congenital heart disease ... Clinical • Under-recognized ... teratogenic GDMT meds
Diagnostic flow-chart to assess and monitor disease severity in the presence of suspected NAFLD and metabolic
and metabolic risk ... EASL–EASD–EASO Clinical ... Guidelines for the management ... #Diagnosis #NASH ... Steatohepatitis #Workup #Algorithm